Ignite Creation Date:
2024-05-05 @ 5:14 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00416546
Status:
COMPLETED
Last Update Posted:
2008-08-11
First Post:
2006-12-27
Brief Title:
Safety of AEB071 in Healthy Volunteers and to Compare the Ethnicity Metabolic and Safety Effects Between Caucasian and Japanese Healthy Subjects
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
A Double Blind Randomized Placebo-Controlled Study of AEB071 in Healthy Volunteers to Evaluate the SafetyTolerability of 14 Day Multiple-Dose AEB071 and Measure the Effect of Ethnicity on Pharmacokinetics Pharmacodynamics and SafetyTolerability in Caucasian and Japanese Subjects Receiving Single and Multiple Doses of AEB071
Status:
COMPLETED
Status Verified Date:
2008-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a study to assess the safety effects after multiple doses of AEB071 in healthy volunteers and to compare the ethnicity metabolic and safety effects between Caucasian and Japanese healthy subjects receiving single and multiple doses of AEB071
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None